Genetic therapy using bone marrow transplantation.
作者信息
Giles R E, Hanania E G, Fu S, Deisseroth A
机构信息
Department of Hematology, University of Texas, MD Anderson Cancer Center, Houston 77030-4009, USA.
出版信息
Cancer Treat Res. 1995;76:271-80. doi: 10.1007/978-1-4615-2013-9_12.
PMID:7577339
Abstract
摘要
相似文献
1
Genetic therapy using bone marrow transplantation.
Cancer Treat Res. 1995;76:271-80. doi: 10.1007/978-1-4615-2013-9_12.
2
Construction of MDR1 vectors for gene therapy.
Methods Enzymol. 1998;292:523-37. doi: 10.1016/s0076-6879(98)92041-9.
3
Gene therapy for human inherited disorders: techniques and status.
Crit Rev Oncol Hematol. 1992 Jul;13(1):33-54. doi: 10.1016/1040-8428(92)90015-i.
4
Retroviral transfer of multidrug transporter to murine hematopoietic stem cells.多药转运蛋白向小鼠造血干细胞的逆转录病毒转移。
Methods Enzymol. 1998;292:546-57. doi: 10.1016/s0076-6879(98)92043-2.
5
Construction of MDR1 adeno-associated virus vectors for gene therapy.用于基因治疗的多药耐药基因1腺相关病毒载体的构建
Methods Enzymol. 1998;292:538-45. doi: 10.1016/s0076-6879(98)92042-0.
6
Treatment of patients with severe combined immunodeficiency due to adenosine deaminase (ADA) deficiency by autologous transplantation of genetically modified bone marrow cells.
Hum Gene Ther. 1992 Oct;3(5):553-8. doi: 10.1089/hum.1992.3.5-553.
7
A Journey in the Development of Gene Therapy for Inherited Disorders of the Bone Marrow.骨髓遗传性疾病基因治疗的发展历程
Hum Gene Ther Clin Dev. 2015 Dec;26(4):203-7. doi: 10.1089/humc.2015.29006.koh.
8
ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.欧洲药品管理局批准腺苷脱氨酶严重联合免疫缺陷症基因疗法进行上市许可。
Mol Ther. 2016 Jun;24(6):1013-1014. doi: 10.1038/mt.2016.98.
9
Gene therapy for primary immunodeficiency.
Biochem Soc Trans. 1997 May;25(2):537-40. doi: 10.1042/bst0250537.
10
Gene therapy for ADA-SCID: defining the factors for successful outcome.腺苷脱氨酶严重联合免疫缺陷症的基因治疗：确定成功治疗的因素
Blood. 2012 Nov 1;120(18):3628-9. doi: 10.1182/blood-2012-08-446559.
Zotero 插件